3‐Arylidene‐N‐hydroxyoxindoles: A New Class of Compounds Endowed with Antitumor Activity
Identifieur interne : 000F23 ( Istex/Curation ); précédent : 000F22; suivant : 000F243‐Arylidene‐N‐hydroxyoxindoles: A New Class of Compounds Endowed with Antitumor Activity
Auteurs : Loana Musso [Italie] ; Raffaella Cincinelli [Italie] ; Valentina Zuco [Italie] ; Michelandrea De Esare [Italie] ; Franco Zunino [Italie] ; Anna Lucia Fallacara [Italie] ; Maurizio Botta [Italie, États-Unis] ; Sabrina Dallavalle [Italie]Source :
- ChemMedChem [ 1860-7179 ] ; 2016-08-19.
Abstract
A series of compounds containing the N‐hydroxyoxindole scaffold were synthesized and evaluated for antitumor activity. The compounds showed potent antiproliferative activity against the wild‐type p53 IGROV‐1 ovarian carcinoma cell line and considerably lower efficacy against the mutant IGROV‐1/Pt1 subline that lacks p53 function. The differential response of ovarian carcinoma cells depending on p53 status was also reflected in the varied susceptibility to apoptosis of the treated cell lines. These results support a role for the p53 transcription factor as a determinant of cytotoxicity. The therapeutic potential of the most promising compound of the series was evaluated in the treatment of an IGROV‐1 xenograft growing as ascitic tumor in mice. Using intraperitoneal administration, daily treatment with the compound for four weeks produced a significant delay in the onset of ascites.
Exploring new scaffolds: A series of 3‐arylidene‐N‐hydroxyoxindoles show potent antiproliferative and pro‐apoptotic activity against wild‐type p53 IGROV‐1 ovarian carcinoma cells and a considerably lower efficacy against the mutant IGROV‐1/Pt1 subline lacking p53 function. These results support a role for this transcription factor as a determinant of cytotoxicity. Treatment of an IGROV‐1 xenograft growing as an ascitic tumor produced a significant delay in the onset of ascites.
Url:
DOI: 10.1002/cmdc.201600225
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000F23
Links to Exploration step
ISTEX:2B842C376A7A410ACAF70F18C1C7E2F1AEBDF50BLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">3‐Arylidene‐N‐hydroxyoxindoles: A New Class of Compounds Endowed with Antitumor Activity</title>
<author><name sortKey="Musso, Loana" sort="Musso, Loana" uniqKey="Musso L" first="Loana" last="Musso">Loana Musso</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Food, Environmental and Nutritional Sciences, Division of Chemistry and Molecular Biology, University of Milan, via Celoria 2, 20133, Milano, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Food, Environmental and Nutritional Sciences, Division of Chemistry and Molecular Biology, University of Milan, via Celoria 2, 20133, Milano</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Cincinelli, Raffaella" sort="Cincinelli, Raffaella" uniqKey="Cincinelli R" first="Raffaella" last="Cincinelli">Raffaella Cincinelli</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Food, Environmental and Nutritional Sciences, Division of Chemistry and Molecular Biology, University of Milan, via Celoria 2, 20133, Milano, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Food, Environmental and Nutritional Sciences, Division of Chemistry and Molecular Biology, University of Milan, via Celoria 2, 20133, Milano</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Zuco, Valentina" sort="Zuco, Valentina" uniqKey="Zuco V" first="Valentina" last="Zuco">Valentina Zuco</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS – Istituto Nazionale dei Tumori, Via Amadeo 42, 20133, Milano, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS – Istituto Nazionale dei Tumori, Via Amadeo 42, 20133, Milano</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="De Esare, Michelandrea" sort="De Esare, Michelandrea" uniqKey="De Esare M" first="Michelandrea" last="De Esare">Michelandrea De Esare</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS – Istituto Nazionale dei Tumori, Via Amadeo 42, 20133, Milano, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS – Istituto Nazionale dei Tumori, Via Amadeo 42, 20133, Milano</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Zunino, Franco" sort="Zunino, Franco" uniqKey="Zunino F" first="Franco" last="Zunino">Franco Zunino</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS – Istituto Nazionale dei Tumori, Via Amadeo 42, 20133, Milano, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS – Istituto Nazionale dei Tumori, Via Amadeo 42, 20133, Milano</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Fallacara, Anna Lucia" sort="Fallacara, Anna Lucia" uniqKey="Fallacara A" first="Anna Lucia" last="Fallacara">Anna Lucia Fallacara</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Biotechnology Chemistry and Pharmaceutical Science, University of Siena, Via Aldo Moro 2, 53100, Siena, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Biotechnology Chemistry and Pharmaceutical Science, University of Siena, Via Aldo Moro 2, 53100, Siena</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Botta, Maurizio" sort="Botta, Maurizio" uniqKey="Botta M" first="Maurizio" last="Botta">Maurizio Botta</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Biotechnology Chemistry and Pharmaceutical Science, University of Siena, Via Aldo Moro 2, 53100, Siena, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Biotechnology Chemistry and Pharmaceutical Science, University of Siena, Via Aldo Moro 2, 53100, Siena</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, BioLife Science Building, Suite 333, 1900 North 12th Street, PA, 19122, Philadelphia, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, BioLife Science Building, Suite 333, 1900 North 12th Street, PA, 19122, Philadelphia</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Dallavalle, Sabrina" sort="Dallavalle, Sabrina" uniqKey="Dallavalle S" first="Sabrina" last="Dallavalle">Sabrina Dallavalle</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Food, Environmental and Nutritional Sciences, Division of Chemistry and Molecular Biology, University of Milan, via Celoria 2, 20133, Milano, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Food, Environmental and Nutritional Sciences, Division of Chemistry and Molecular Biology, University of Milan, via Celoria 2, 20133, Milano</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>E-mail: sabrina.dallavalle@unimi.it</mods:affiliation>
<country wicri:rule="url">Italie</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:2B842C376A7A410ACAF70F18C1C7E2F1AEBDF50B</idno>
<date when="2016" year="2016">2016</date>
<idno type="doi">10.1002/cmdc.201600225</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-7S7FNDF2-7/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000F23</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000F23</idno>
<idno type="wicri:Area/Istex/Curation">000F23</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">3‐Arylidene‐N‐hydroxyoxindoles: A New Class of Compounds Endowed with Antitumor Activity</title>
<author><name sortKey="Musso, Loana" sort="Musso, Loana" uniqKey="Musso L" first="Loana" last="Musso">Loana Musso</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Food, Environmental and Nutritional Sciences, Division of Chemistry and Molecular Biology, University of Milan, via Celoria 2, 20133, Milano, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Food, Environmental and Nutritional Sciences, Division of Chemistry and Molecular Biology, University of Milan, via Celoria 2, 20133, Milano</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Cincinelli, Raffaella" sort="Cincinelli, Raffaella" uniqKey="Cincinelli R" first="Raffaella" last="Cincinelli">Raffaella Cincinelli</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Food, Environmental and Nutritional Sciences, Division of Chemistry and Molecular Biology, University of Milan, via Celoria 2, 20133, Milano, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Food, Environmental and Nutritional Sciences, Division of Chemistry and Molecular Biology, University of Milan, via Celoria 2, 20133, Milano</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Zuco, Valentina" sort="Zuco, Valentina" uniqKey="Zuco V" first="Valentina" last="Zuco">Valentina Zuco</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS – Istituto Nazionale dei Tumori, Via Amadeo 42, 20133, Milano, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS – Istituto Nazionale dei Tumori, Via Amadeo 42, 20133, Milano</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="De Esare, Michelandrea" sort="De Esare, Michelandrea" uniqKey="De Esare M" first="Michelandrea" last="De Esare">Michelandrea De Esare</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS – Istituto Nazionale dei Tumori, Via Amadeo 42, 20133, Milano, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS – Istituto Nazionale dei Tumori, Via Amadeo 42, 20133, Milano</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Zunino, Franco" sort="Zunino, Franco" uniqKey="Zunino F" first="Franco" last="Zunino">Franco Zunino</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS – Istituto Nazionale dei Tumori, Via Amadeo 42, 20133, Milano, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS – Istituto Nazionale dei Tumori, Via Amadeo 42, 20133, Milano</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Fallacara, Anna Lucia" sort="Fallacara, Anna Lucia" uniqKey="Fallacara A" first="Anna Lucia" last="Fallacara">Anna Lucia Fallacara</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Biotechnology Chemistry and Pharmaceutical Science, University of Siena, Via Aldo Moro 2, 53100, Siena, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Biotechnology Chemistry and Pharmaceutical Science, University of Siena, Via Aldo Moro 2, 53100, Siena</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Botta, Maurizio" sort="Botta, Maurizio" uniqKey="Botta M" first="Maurizio" last="Botta">Maurizio Botta</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Biotechnology Chemistry and Pharmaceutical Science, University of Siena, Via Aldo Moro 2, 53100, Siena, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Biotechnology Chemistry and Pharmaceutical Science, University of Siena, Via Aldo Moro 2, 53100, Siena</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, BioLife Science Building, Suite 333, 1900 North 12th Street, PA, 19122, Philadelphia, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, BioLife Science Building, Suite 333, 1900 North 12th Street, PA, 19122, Philadelphia</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Dallavalle, Sabrina" sort="Dallavalle, Sabrina" uniqKey="Dallavalle S" first="Sabrina" last="Dallavalle">Sabrina Dallavalle</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Food, Environmental and Nutritional Sciences, Division of Chemistry and Molecular Biology, University of Milan, via Celoria 2, 20133, Milano, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Food, Environmental and Nutritional Sciences, Division of Chemistry and Molecular Biology, University of Milan, via Celoria 2, 20133, Milano</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>E-mail: sabrina.dallavalle@unimi.it</mods:affiliation>
<country wicri:rule="url">Italie</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">ChemMedChem</title>
<title level="j" type="sub">23rd National Meeting on Medicinal Chemistry (NMMC)</title>
<title level="j" type="alt">CHEMMEDCHEM</title>
<idno type="ISSN">1860-7179</idno>
<idno type="eISSN">1860-7187</idno>
<imprint><biblScope unit="vol">11</biblScope>
<biblScope unit="issue">16</biblScope>
<biblScope unit="page" from="1700">1700</biblScope>
<biblScope unit="page" to="1704">1704</biblScope>
<biblScope unit="page-count">5</biblScope>
<date type="published" when="2016-08-19">2016-08-19</date>
</imprint>
<idno type="ISSN">1860-7179</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1860-7179</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">A series of compounds containing the N‐hydroxyoxindole scaffold were synthesized and evaluated for antitumor activity. The compounds showed potent antiproliferative activity against the wild‐type p53 IGROV‐1 ovarian carcinoma cell line and considerably lower efficacy against the mutant IGROV‐1/Pt1 subline that lacks p53 function. The differential response of ovarian carcinoma cells depending on p53 status was also reflected in the varied susceptibility to apoptosis of the treated cell lines. These results support a role for the p53 transcription factor as a determinant of cytotoxicity. The therapeutic potential of the most promising compound of the series was evaluated in the treatment of an IGROV‐1 xenograft growing as ascitic tumor in mice. Using intraperitoneal administration, daily treatment with the compound for four weeks produced a significant delay in the onset of ascites.</div>
<div type="abstract" xml:lang="en">Exploring new scaffolds: A series of 3‐arylidene‐N‐hydroxyoxindoles show potent antiproliferative and pro‐apoptotic activity against wild‐type p53 IGROV‐1 ovarian carcinoma cells and a considerably lower efficacy against the mutant IGROV‐1/Pt1 subline lacking p53 function. These results support a role for this transcription factor as a determinant of cytotoxicity. Treatment of an IGROV‐1 xenograft growing as an ascitic tumor produced a significant delay in the onset of ascites.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F23 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 000F23 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= Istex |étape= Curation |type= RBID |clé= ISTEX:2B842C376A7A410ACAF70F18C1C7E2F1AEBDF50B |texte= 3‐Arylidene‐N‐hydroxyoxindoles: A New Class of Compounds Endowed with Antitumor Activity }}
![]() | This area was generated with Dilib version V0.6.33. | ![]() |